Category: Therapies
-

Future of Optogenetics and its Limitations in Slowing Alzheimer’s Disease Through Astrocyte Targeting
Renia Ahmed ’30 Alzheimer’s Disease (AD) is a progressive neurodegenerative disease and the most common cause of dementia, affecting millions of people worldwide. Amyloid plaques and tau protein tangles are pathological hallmarks of AD. Normally, tau proteins help maintain the internal structures that transport nutrients throughout neurons; however, during AD, tau becomes altered and forms…
-

Controversy Surrounding He Jiankui and the First ‘CRISPR Babies’
Rachel Lim ‘29 On November 28, 2018, Chinese geneticist He Jiankui announced the birth of the first gene-edited human babies in the world. As soon as he finished presenting his work at the Second International Summit on Human Genome Editing in Hong Kong, he was promptly bombarded by questions from scientists and journalists in the…
-

Cancer and the Gut: How Bacteria Could Improve Responses to Immunotherapy
Rachel Lim ‘29 In 1863, German physician Rudolf Virchow, “the father of modern pathology,” observed the increased presence of white blood cells in abnormal tissue growth and was the first to propose the relationship between immune function and cancer. From the 1890s to the 1930s, doctors observed that some bacterial infections caused tumors to shrink.…
